InfiNano over the years have developed capability across therapeutic areas. A strategic evolution from device-focused dental applications to a comprehensive nanotechnology enabled therapeutics platform. Our initial commercialization of nano-diamond surgical burs provided critical insights into medical device market dynamics, regulatory pathways, and value proposition optimization.
Leveraging these operational learnings, we have strategically pivoted to address higher-impact therapeutic challenges with superior unit economics and scalable market opportunities. This transformation reflects a disciplined approach to capital allocation and technology application, focusing on therapeutic areas with significant unmet medical needs, clear clinical differentiation, and favorable reimbursement landscapes.
Our repositioning leverages India’s competitive advantages in pharmaceutical R&D, process chemistry, and GMP manufacturing while accessing global markets through strategic partnerships and regulatory pathway optimization.
